TORONTO and DUREN, Germany, Nov. 8 2022
/CNW/ - GBLT Corp. (TSXV: GBLT) ("GBLT" or the
"Company") is pleased to announce that it is continuing to
receive orders for their Dr. Senst personal healthcare product line
from major European retailers. This current order amounts to
€825,223 (~$1.1 million CAD)* for the
2023 pipeline. This order is in addition to an already received
order of €809,162 ($1.09 million CAD)
from earlier this year making the cumulative amount to €1,644,385
(~$2.2 million CAD) to be delivered
to the client starting January
2023.
"We continue to significantly increase our shelf presence in
this International Retailer, as our Dr. Senst brand within the
healthcare consumer market continues to be trusted and demanded by
consumers," said Dr. Thilo Senst,
CEO of GBLT. "Despite the economic volatility in Europe and the world today, GBLT products are
continuing to experience an abundance of demand due to its quality
and price advantage over other competitor products. The
international retailer remains a stable source of sticky, high
margin income which has been an important source of our growth over
the past few years. We continue to expand our business product
lines and will continue to meet the increase demand for our Dr.
Senst personal healthcare products to continue driving significant
growth in our sales and profitability for this year and next."
*Exchange rate 1.34
CAD/EURO (2022-11-03) as per
https://www.bankofcanada.ca/rates/exchange/daily-exchange-rates/
|
About GBLT:
GBLT Corp., through its operating company, GBT GmbH, designs,
manufactures and supplies mobile storage, and battery solutions.
GBLT is also a leading provider of renewable energy solutions via
its solar division, participating in the rapidly growing solar
energy market. In addition, the Company offers consumer healthcare
and wellness products to some of the largest retail chains across
the globe. GBT is also an official licensee for AGFAPHOTO mobile
energy products. The Company's branded healthcare and wellbeing
products are primarily sold throughout Europe under Dr. Senst brand.
For more information, please visit www.gbt-international.com
and www.gbltcorp.com.
Forward-Looking
Information
Certain statements in this news release, which are not
historical in nature, constitute "forward looking statements"
within the meaning of that phrase under applicable Canadian
securities law. These statements include, but are not limited to,
statements or information concerning the Company's proposed
activities under the Agreement, the Company's ability to achieve
sales, commercial or otherwise, from its products, and the
expectations of the Company regarding funding payments due pursuant
to the Agreement. These statements reflect management's current
assumptions and expectations and by their nature are subject to
certain underlying assumptions, known and unknown risks and
uncertainties and other factors which may cause actual results,
performance or events to be materially different from those
expressed or implied by such forward looking statements. Except as
required pursuant to applicable securities laws, the Company will
not update these forward-looking statements to reflect events or
circumstances after the date hereof. More detailed information
about potential factors that could affect financial results is
included in the documents filed from time to time with the Canadian
securities regulatory authorities by the Company. Readers are
cautioned not to place undue reliance on forward looking
statements.
Neither the TSX Venture Exchange nor its
Regulation Services Provider
(as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE GBLT Corp.